Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 54.82 K327.7 K169.33 K193.76 K 745.61 K Research & development ———— — Operating income -63.42 K-349.25 K-202.36 K-233.45 K -848.48 K Non-Operating Income, Total 0951.68 K1.69 M1.52 M 4.16 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 0951.68 K1.69 M1.52 M 4.16 M Unusual income/expense ———— — Pretax income -63.42 K602.43 K1.48 M1.29 M 3.31 M Equity in earnings ———— — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -54.82 K602.43 K1.48 M1.29 M 3.31 M Discontinued operations ———— — Net income -54.82 K602.43 K1.48 M1.29 M 3.31 M Dilution adjustment —-22.37 M25.56 M1.52 M — Preferred dividends —-22.37 M25.55 M1.52 M — Diluted net income available to common stockholders -63.42 K602.43 K1.48 M1.29 M 3.31 M Basic earnings per share (Basic EPS) -0.010.160.320.2 0.67 Diluted earnings per share (Diluted EPS) -0.010.160.320.2 0.67 Average basic shares outstanding 5.69 M20.87 M29.99 M48.61 M — Diluted shares outstanding 5.69 M22.19 M30.88 M48.61 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —